检索历史清除

首页> Blood: The Journal of the American Society of Hematology> Repeat Infusion of CD19-Specific Chimeric Antigen Receptor T-Cell Could Improve the Efficacy with Consistent Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Repeat Infusion of CD19-Specific Chimeric Antigen Receptor T-Cell Could Improve the Efficacy with Consistent Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

导出原文传递

翻译打印收藏纠错

作者： Hu, Jianda ^[1] ; Yang, Ting ^[2] ; Yang, Xiaozhu ; Xian, Na ; Chen, Yanxin ; Jiang, Peifang ; Huang, Gangxiong

作者单位： Fujian Med Univ, Dept Hematol, Fujian Prov Key Lab Hematol, Union Hosp,Fujian Inst Hematol, Fuzhou ^[1] Fujian Med Univ, Inst Immunotherapy, Fuzhou, Fujian, Peoples R China ^[2]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交